---
schema_version: "secwatch.filing_event.v1"
accession: "0001562762-25-000131"
form_type: "8-K"
ticker: "GMED"
cik: "0001237831"
company_name: "GLOBUS MEDICAL INC"
filed_at: "2025-05-15T23:59:59+00:00"
generated_at: "2026-05-21T04:34:53.851814+00:00"
event_type: "other_material"
sentiment: "positive"
materiality_score: 0.55
calibrated_materiality_score: 0.55
confidence: "high"
source: SEC EDGAR
---

# Globus Medical authorizes $500M share repurchase program

## Summary
- Board authorized up to $500M buyback of Class A common stock.
- CFO cites disconnect between intrinsic value and market valuation.
- Repurchases at management's discretion; no time limit, can be suspended.
- Funding from cash reserves; program aligns with capital allocation strategy.

## SEC filing metadata
- accession: 0001562762-25-000131
- form_type: 8-K
- ticker: GMED
- cik: 0001237831
- company_name: GLOBUS MEDICAL INC
- filed_at: 2025-05-15T23:59:59+00:00
- event_type: other_material
- sentiment: positive
- materiality_score: 0.55
- calibrated_materiality_score: 0.55
- confidence: high
- sec_items: 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1237831/000156276225000131/0001562762-25-000131-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1237831/000156276225000131/gmed-20250515x8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001562762-25-000131
- JSON: https://secwatch.observer/filing/0001562762-25-000131.json
- Plain text: https://secwatch.observer/filing/0001562762-25-000131.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.